New Fortress Energy
NFE
Teradata Corp
TDC
Enerpac Tool
EPAC
DexCom
DXCM
Precision Drilling
PDS
US Stock MarketDetailed Quotes
NRXP NRX Pharmaceuticals
- 2.3500
- +0.2800+13.53%
Close Mar 14 16:00 ET
- 2.3500
- 0.00000.00%
Post 18:24 ET
39.75MMarket Cap-1.11P/E (TTM)
2.4050High2.0800Low259.44KVolume2.0900Open2.0700Pre Close594.26KTurnover1.85%Turnover RatioLossP/E (Static)16.92MShares6.010052wk High-2.11P/B32.96MFloat Cap1.100052wk Low--Dividend TTM14.03MShs Float769.9000Historical High--Div YieldTTM15.70%Amplitude1.1000Historical Low2.2900Avg Price1Lot Size
About NRX Pharmaceuticals Company
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.
Company Profile
SymbolNRXP
Company NameNRX Pharmaceuticals
Listing DateDec 1, 2017
Founded2017
CEODr. Jonathan C. Javitt,M.D.,M.P.H.
MarketNASDAQ
Fiscal Year Ends12-31
Address1201 Orange Street,Suite 600
CityWilmington
ProvinceDelaware
CountryUnited States of America
Zip Code19801
Phone1-484-254-6134
Websitehttp://www.nrxpharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Jonathan C. Javitt,M.D.,M.P.H.
- Chairman of the Board, Chief Scientist and Interim Chief Executive Officer
- 630.20K
- Matthew Duffy
- Chief Business Officer
- --
- Michael S. Abrams
- Chief Financial Officer
- --
- Dr. Riccardo Panicucci, PhD
- Chief Manufacturing and Technology Officer and Technical Operations Advisor
- --
- Mike Taylor
- Director
- --
- Dr. Dennis McBride, PhD
- Director
- --
- Patrick J. Flynn
- Independent Director
- 67.50K
- Chaim Hurvitz
- Independent Director
- 52.50K